Tonix Pharmaceuticals Holding (TNXP) Operating Leases (2019 - 2026)

Tonix Pharmaceuticals Holding has reported Operating Leases for 8 years, with the latest figure at $1.3 million in Q2 2026.

• On a quarterly basis, Operating Leases rose 158.54% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $1.3 million, a 158.54% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 230.73% from the prior year.
• Operating Leases was $1.3 million for Q2 2026 at Tonix Pharmaceuticals Holding, down from $1.3 million in the prior quarter.
• The five-year high for Operating Leases was $1.3 million in Q1 2026, with the low at $328000.0 in Q4 2022.
• Average Operating Leases over 5 years is $831666.7, with a median of $821000.0 recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Operating Leases plunged 43.35% in 2024, then jumped 230.73% in 2025.
• Over 5 years, Operating Leases stood at $328000.0 in 2022, then soared by 92.68% to $632000.0 in 2023, then slumped by 43.35% to $358000.0 in 2024, then surged by 230.73% to $1.2 million in 2025, then climbed by 7.43% to $1.3 million in 2026.
• The last three Operating Leases figures came in at $1.3 million (Q2 2026), $1.3 million (Q1 2026), and $1.2 million (Q4 2025), per Business Quant data.